2-Hydrazino-4-(trifluoromethyl)pyrimidine CAS:197305-97-8

2-Hydrazinoquinoline has a variety of notable applications, particularly in the fields of medicinal chemistry, pharmaceuticals, and material science. One of the primary uses of this compound is in the search for new therapeutic agents. Its structure allows it to interact with various enzymes and receptors, making it a potential candidate for developing drugs aimed at treating cancer and infectious diseases. Research has indicated that derivatives of 2-hydrazinoquinoline exhibit promising pharmacological activities, such as anticancer and antimicrobial properties, warranting further investigation for their potential efficacy. In cancer research, 2-hydrazinoquinoline and its derivatives are being studied for their ability to inhibit tumor growth and suppress the proliferation of cancer cells. The compound's hydrazine moiety may allow for the formation of reactive intermediates, which can provoke apoptosis in malignant cells, thus paving the way for the development of novel anticancer therapies. Moreover, 2-hydrazinoquinoline is important in the synthesis of various heterocyclic compounds. Due to its unique chemical structure, it acts as a valuable intermediate in synthetic chemistry, allowing researchers to create a diverse range of derivatives with varied biological activities. This property aids in the design and development of new drugs and materials with specific functions. In addition, the compound can be utilized in the preparation of luminescent materials and in applications related to organic electronics, thus extending its utility beyond medicinal chemistry. This multifaceted approach enhances its appeal in both academic research and industrial applications. Overall, 2-hydrazinoquinoline stands as a significant compound in the advancement of medicinal chemistry and materials science, demonstrating its potential in various therapeutic and synthetic projects.